Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Antioxidant
68%
Cardiotoxicity
61%
Parkinson's Disease
56%
Alzheimer's Disease
56%
Disease
55%
Heart Infarction
53%
Caryophyllene
52%
Diabetes Mellitus
49%
Isoprenaline
48%
Doxorubicin
47%
Heart Muscle Injury
45%
Cannabinoid
41%
Bisabolol
41%
Cytokine
40%
Sesquiterpene
38%
Cannabinoid 2 Receptor
35%
Rotenone
35%
Isoproterenol-Induced Myocardial Infarction
34%
Dopamine Receptor Stimulating Agent
34%
Rat Model
33%
Neuroprotective Agent
32%
Mouse
31%
Anti-Inflammatory Drug
26%
Infection
26%
Phytochemical
24%
Nerolidol
23%
Nervous System Inflammation
22%
Nerve Degeneration
21%
Receptor
21%
Streptozotocin
21%
Peroxisome Proliferator Activated Receptor
20%
Transcription Factor Nrf2
20%
Lactate Dehydrogenase
20%
Myocardial Ischemia Reperfusion Injury
19%
Nephrotoxicity
18%
Wistar Rat
17%
Eplerenone
17%
Cisplatin
17%
Thymoquinone
17%
Colitis
17%
Sulfone
17%
Terbufos
17%
Histamine H3 Receptor Antagonist
17%
Cardiovascular Disease
17%
Acetylcholinesterase
15%
Malignant Neoplasm
14%
Autism
14%
Neurologic Disease
13%
Metabolic Syndrome X
13%
Malonaldehyde
13%
Adrenergic Receptor Stimulating Agent
12%
Degenerative Disease
12%
Terpene
12%
Diabetic Cardiomyopathy
12%
Coronavirinae
12%
Antiapoptotic
12%
Hippophae rhamnoides
11%
Commiphora
11%
Apigenin
11%
Toxicodendron Pubescens
11%
Rhus
11%
Transcription Factors
11%
Pyrazinamide
11%
Phyllanthus Emblica
11%
Sodium Valproate
11%
Lycopene
11%
Molecular Pathology
11%
Polyphenol
11%
Curcumin
11%
Disulfiram
11%
Esterase Inhibitor
11%
Kidney Injury
10%
Hyperglycemia
10%
Dyslipidemia
10%
Glycogen Synthase Kinase
10%
Combination Therapy
10%
Creatine Kinase MB
10%
Glutathione
10%
Heart Muscle Necrosis
10%
Compulsion
9%
Non Insulin Dependent Diabetes Mellitus
9%
Antiinfective Agent
9%
SARS Coronavirus
9%
Nutraceutical
9%
Catalase
9%
Clinical Trial
9%
Tumor Necrosis Factor
9%
Injury
9%
Drug Development
9%
Pharmacokinetics
9%
Subcutaneous Injection
9%
Bioavailability
8%
Mortality Rate
8%
Pandemic
8%
Adult Respiratory Distress Syndrome
8%
Endocannabinoid System
8%
Heart Injury
8%
Natural Product
8%
Inflammasome
8%
Keyphrases
Myocardial Ischemic Injury
11%
Neuroprotective Potential
11%
Myocardial Ischemia-reperfusion Injury
11%
CB2 Receptor
9%
Isoproterenol
9%
Therapeutic Potential
8%
Myocardial Fibrosis
7%
Parkinson's Disease
7%
Alzheimer's Disease
7%
Kaempferol
6%
Wistar Rats
6%
Cardioprotection
6%
Cardiotoxicity
6%
Oxidative Inflammation
6%
Myocardial Injury
6%
Oxidative Stress
6%
Caryophyllene
5%
Ethanol-induced Liver Injury
5%
Voluntary Alcohol Consumption
5%
Cannabinoid Receptor 2
5%
Pharmacological Mechanism
5%
FBXW7
5%
Kolkata
5%
Management Journals
5%
Therapeutic Review
5%
Rho Associated Coiled-coil Containing Protein Kinase 1
5%
Sea Buckthorn
5%
Inula Racemosa
5%
Aloin
5%
Notch1
5%
CaSki
5%
Hes1
5%
Valeric Acid
5%
Hypertension
5%
Pentacyclic Triterpenes
5%
Anticonvulsant Drugs
5%
Serum Glycoprotein
5%
Retraction Notice
5%
Inflammasome
5%
Fatty Acid Synthase
5%
Natural Drugs
5%
Pilocarpine-induced Epilepsy
5%
Recent Update
5%
β-caryophyllene
5%
Molecular Docking
5%
Phytocannabinoids
5%
Place Preference
5%
Cancer Therapeutics
5%
Survival Study
5%
N-acetylcysteine
5%
Cellular Lifespan
5%
Ventricular Function
5%
Eplerenone
5%
Enlightenment
5%
Autism Treatment
5%
Commiphora mukul
5%
Isoproterenol-induced Myocardial Infarction
5%
Gene Editing
5%
Heat Shock Protein 27 (HSP27)
5%
Glycyrrhizic Acid
5%
Coiled-coil Containing Protein Kinase 2
5%
Anti-lipid Peroxidation
5%
Immunoexpression
5%
Copper Chelates
5%
Acute Nephrotoxicity
5%
Natural Medicine
5%
Parkinson's Disease Model
5%
Rotenone Model
5%
Genipin
5%
Myocardial Infarction
5%
Keap1-Nrf2
5%
Punarnava
5%
Boerhaavia Diffusa
5%
Chronic Cardiotoxicity
5%
Pulp Oil
5%
Optimization Evaluation
5%
Nanostructured Lipid Nanocarriers
5%
Biological Tools
5%
Acute Cardiotoxicity
5%
Kainic Acid
5%
Status Epilepticus
5%
Pulmonary Delivery
5%
Cellular Abnormalities
5%
Drug Delivery & Targeting
5%
Benfotiamine
5%
Toxicodendron Pubescens
5%
Preparation Optimization
5%
Nanoparticle Preparation
5%
Solid Lipid Nanoparticles
5%
Rhus Tox
5%
Citronellol
5%
Diabetes Pathogenesis
5%
Acetaminophen-induced Liver Injury
5%
Nigrostriatal Pathway
5%
Urine Pharmacokinetics
5%
Emblica Officinalis Gaertn
5%
Pyrazinamide
5%
Primary Progressive
5%
Amla
5%
Anxiolytic Drugs
5%